Kent Lake PR’s Emergent Biosolutions EBS Stock Holding History

Kent Lake PR’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-200,000	Closed	-$1.67M	–	46
2024 Q3	$1.67M	Buy	+200,000	New	+$1.82M	0.66%	40

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Kent Lake PR's EBS Position: Q4 2024 in Review

Kent Lake PR sold out of Emergent Biosolutions (EBS) in Q4 2024, closing a stake of 200,000 shares — an estimated $1.67M sold.

Kent Lake PR first reported a position in EBS in Q3 2024 and held it in 1 quarter. The position peaked at $1.67M in Q3 2024. 156 funds tracked by Wall St. Rank hold EBS as of Q4 2024.

Kent Lake PR reported no remaining Emergent Biosolutions position as of Q4 2024 after selling out during the quarter.
Kent Lake PR sold 200,000 Emergent Biosolutions shares in Q4 2024, an estimated $1.67M.
Kent Lake PR first reported a position in Emergent Biosolutions in Q3 2024 and held it in 1 quarter.
Kent Lake PR's Emergent Biosolutions position peaked at $1.67M in Q3 2024.
156 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2024.

Based on Kent Lake PR's 13F filing for Q4 2024, filed 14 Feb 2025.